期刊文献+

118例神经病理性癌痛临床特点与治疗 被引量:9

下载PDF
导出
摘要 19%~36%癌痛患者混合有神经病理性疼痛(neuropathicpain,NP),发生原因主要与肿瘤直接侵犯压迫神经有关,也有一部分与肿瘤治疗相关。国际疼痛学会(IASP)将NP定义为中枢或外周神经损伤或功能障碍引起的疼痛,临床表现为针刺样、烧灼样、电击样痛,并伴有感觉超敏(allodynia)、感觉过敏(hyperesthesia)或感觉异常(paresthesia)。
出处 《中国癌症杂志》 CAS CSCD 北大核心 2011年第11期898-900,共3页 China Oncology
  • 相关文献

参考文献15

  • 1Edward H.Eberhardt.Source-detector spectral matching factors.Applied Optics,1968,7(10):2037-2047
  • 2李蔚,常本康.GaAs光电阴极与景物反射光谱的光谱匹配系数[J].光子学报,1999,28(9):857-859. 被引量:6
  • 3Li Wei,Chang Benkang.Spectral matching factors between GaAs and multialkali photocathodes and reflective radiation of objects.Optical Engineering,2001,40(5):674-678
  • 4陈庆佑.二代象增强器的可靠性[J].红外技术,1998,20(1):23-26. 被引量:2
  • 5Richards E A.Contrast-enhancement in imaging devices by selection of input photosurface spectral response.AEEP,1969,28B:661-675
  • 6BENNETT M I,SMITH B H,TORRANCE N,et al:The S-LANSS score for identifying pain of predominantly neuropathic origin:Validation for use in clinic and postal research[J].J Pain,2005,6(3):149-158.
  • 7BOUHASSIRA D,ATTAL N,ALCHAAR H.Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)[J].Pain,2005,114(1-2):29-36.
  • 8GIBBY C R,MORROW P K,BENNETT M I,et al.Neuropathic pain in breast cancer survivors:Using the ID Pain as a screening tool[J].J Pain Symptom Manag,2010,39(5):882-889.
  • 9CARVER A,FOLEY K.Facts and an open mind should guide clinical practice[J].Curr Neurol Neurosci Rep,2001,1(2):97-98.
  • 10MERCADANTE S,PORTENOY R K.Opioid poorlyresponsive cancer pain.Part 3.Clinical strategies to improve opioid responsiveness[J].J Pain Symptom Manage,2001,21(4):338-354.

二级参考文献2

  • 1红外技术第14卷(1992年)总目次索引[J]红外技术,1992(06).
  • 2陈庆佑.主动式红外夜视仪中的几个重要参数问题[J]红外技术,1985(04).

共引文献5

同被引文献88

  • 1曹启旺,黄东,徐慧巧,吴礼平,谷思汉.普瑞巴林联合鞘内输注舒芬太尼治疗骨转移癌爆发痛的临床研究[J].中南大学学报(医学版),2014,39(4):384-388. 被引量:10
  • 2刘生智,贺锋,薛利军.蛛网膜下腔持续泵注吗啡治疗晚期癌痛[J].实用疼痛学杂志,2005,1(3):143-144. 被引量:3
  • 3Vadaloca A, Moka E. Opioid location in patients with cancer a review of the current literature. J Opioid Mang,2008,4(4) : 213-250.
  • 4Currow DC, Sprupt O, Hardy J. Defining ret'ractory pain in cancer for clinicians and researchers. J Palliat Med, 2012, 15 (1):5-6.
  • 5Edrington JM, Wong C, Dodd M, et al. Barriers to cancer pain management in a community sample of chinese american cancer patients, J Pain Symptom Manage, 2009, 37 (4):665-675.
  • 6Mansor M,Cardosa MS, Vijayan R, et al. Prevalence of pain as a sympton in advanced cancer patients. Abstracts of the 12th Word Congress on Pain, 2008.
  • 7Lilot M, Meuret P,Bouvet L, et al. Hypobaric spinal anes thesia with ropivacaine plus sufentanyl for traumatic femoral neck surgery in the elderly: a dose-response study. Anesth Analg, 2013,117(1) : 259-264.
  • 8Carnorcia M, Capogna G, Berritta C, et al. The relative po tencies for motor block after intrathecal ropivacaine, levobupivaeaine, and bupivacaine. Anesth Analg, 2007, 104 (4) :904-907.
  • 9Chai T,Bruel BM, Nouri KH, et al. Complications after in tratheeal drug delivery due to the underlying malignancy in two patients with intractable cancer pain. Pain Physician, 2013,16(2) : E107-111.
  • 10Tan T, Barry P, Reken S, et al. Pharmacological management of neuropathic pain in non - specialist settings: summary of NICE guidance [ J ]. BMJ ,2010,340 : c1079.

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部